Initially, the managers note that U.S. statistics in the form of the manufacturing Purchasing Managers' Index took a clear step up during the month, suggesting an improvement in the economic outlook. At the same time, long-term market interest rates fell during the period, and the U.S. ten-year yield was once again trading around 4 percent.
Among the month's top contributors were Nokia and Sobi, as well as forestry and engineering companies. The positive share price performance in the larger engineering companies continued, with several reaching new highs. Sobi benefited, among other things, from new targets to double revenue by 2030, while the company's adjusted earnings per share grew by 42 percent.
Bioarctic reported a strong fourth quarter driven by the continued global expansion of the Alzheimer's drug Leqembi. Net sales rose to SEK 184 million and operating profit improved to SEK 33 million. The company's cash position increased to nearly SEK 2.2 billion, and given the strong financial position, the board proposed a dividend of SEK 2 per share.
"During the quarter, new data was also presented indicating that continuous treatment can delay disease progression by up to 8.3 years," the managers write.
Regarding portfolio activity, the fund made purchases in SEB, Nordea, and Swedbank during February. At the same time, sales were made in Essity, Nokia, and SKF.
The largest equity holdings in the fund's portfolio at the end of the month were Ericsson, SKF, and Autoliv, with portfolio weights of 8.8, 7.0, and 6.6 percent, respectively.
The fund had its largest geographical exposure to Sweden with a weight of 70.5 percent, followed by Finland and Germany with exposures of 21.9 and 4.6 percent, respectively.
| Lannebo Sverige Plus, % | February, 2026 |
| Fund M/M, change in percent | 7.0 |
| Index M/M, change in percent | 4.5 |
| Fund YTD, change in percent | 5.5 |
| Index YTD, change in percent | 6.9 |
